Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.200
+0.080 (2.56%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Kiora Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.79 | 2.45 | 5.96 | 7.85 | 1.19 | Upgrade
|
| Short-Term Investments | 23 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 26.79 | 2.45 | 5.96 | 7.85 | 1.19 | Upgrade
|
| Cash Growth | 991.47% | -58.85% | -24.06% | 562.47% | -68.61% | Upgrade
|
| Accounts Receivable | 0.6 | - | - | - | - | Upgrade
|
| Other Receivables | 0.27 | 2.05 | 1.37 | 0.53 | 0.09 | Upgrade
|
| Receivables | 0.87 | 2.05 | 1.37 | 0.53 | 0.09 | Upgrade
|
| Prepaid Expenses | 2.04 | 0.23 | 0.34 | 0.61 | 0.45 | Upgrade
|
| Total Current Assets | 29.71 | 4.74 | 7.68 | 8.99 | 1.73 | Upgrade
|
| Property, Plant & Equipment | 0.06 | 0.11 | 0.17 | 0.28 | 0.11 | Upgrade
|
| Goodwill | - | - | - | - | 3.63 | Upgrade
|
| Other Intangible Assets | - | 0.12 | 0.14 | 0.17 | 0.19 | Upgrade
|
| Long-Term Deferred Charges | 6.69 | 8.7 | 10.6 | 10.6 | 9.54 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.05 | 0.08 | 0.09 | 0.1 | Upgrade
|
| Total Assets | 36.48 | 13.71 | 18.68 | 20.13 | 15.3 | Upgrade
|
| Accounts Payable | 0.42 | 0.21 | 1.01 | 0.16 | 0.43 | Upgrade
|
| Accrued Expenses | 2.26 | 1.38 | 1.84 | 1.33 | 1.29 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.21 | Upgrade
|
| Current Portion of Leases | 0.02 | 0.05 | 0.11 | 0.12 | 0.05 | Upgrade
|
| Current Income Taxes Payable | 2.33 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0.98 | - | 0.32 | - | - | Upgrade
|
| Total Current Liabilities | 6.01 | 1.63 | 3.27 | 1.61 | 1.98 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.28 | Upgrade
|
| Long-Term Leases | 0.03 | 0.06 | - | 0.09 | 0.04 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.49 | 0.78 | 0.69 | 0.8 | 0.73 | Upgrade
|
| Other Long-Term Liabilities | 4.19 | 5.13 | 3.31 | 3.05 | 2.55 | Upgrade
|
| Total Liabilities | 10.72 | 7.6 | 7.27 | 5.55 | 5.57 | Upgrade
|
| Common Stock | 0.27 | 0.08 | 0.02 | 0 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 169.16 | 153.19 | 146.04 | 135.54 | 116.78 | Upgrade
|
| Retained Earnings | -143.38 | -146.98 | -134.46 | -120.88 | -107.11 | Upgrade
|
| Comprehensive Income & Other | -0.28 | -0.18 | -0.18 | -0.09 | -0 | Upgrade
|
| Total Common Equity | 25.76 | 6.11 | 11.41 | 14.58 | 9.73 | Upgrade
|
| Shareholders' Equity | 25.76 | 6.11 | 11.41 | 14.58 | 9.73 | Upgrade
|
| Total Liabilities & Equity | 36.48 | 13.71 | 18.68 | 20.13 | 15.3 | Upgrade
|
| Total Debt | 0.06 | 0.11 | 0.11 | 0.21 | 0.57 | Upgrade
|
| Net Cash (Debt) | 26.73 | 2.35 | 5.86 | 7.65 | 0.61 | Upgrade
|
| Net Cash Growth | 1038.72% | -59.93% | -23.37% | 1150.70% | -83.45% | Upgrade
|
| Net Cash Per Share | 6.48 | 4.36 | 72.00 | 285.39 | 47.93 | Upgrade
|
| Filing Date Shares Outstanding | 3 | 2.92 | 0.21 | 0.04 | 0.02 | Upgrade
|
| Total Common Shares Outstanding | 3 | 0.86 | 0.2 | 0.04 | 0.02 | Upgrade
|
| Working Capital | 23.7 | 3.1 | 4.41 | 7.38 | -0.26 | Upgrade
|
| Book Value Per Share | 8.58 | 7.14 | 57.15 | 414.44 | 630.41 | Upgrade
|
| Tangible Book Value | 25.76 | 5.99 | 11.26 | 14.41 | 5.9 | Upgrade
|
| Tangible Book Value Per Share | 8.58 | 7.00 | 56.43 | 409.64 | 382.58 | Upgrade
|
| Machinery | 0.01 | 0.01 | 0.15 | 0.16 | 0.1 | Upgrade
|
| Leasehold Improvements | - | - | 0.02 | 0.02 | 0.02 | Upgrade
|
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.